ARIPIPRAZOLE ORAL
Manufacturer: Camber Pharmaceuticals, Inc.
Score: 144.0
Aripiprazole is an atypical antipsychotic used for the treatment of schizophrenia, bipolar disorder, irritability associated with autistic disorder, and Tourette's disorder. It has a boxed warning for increased mortality in elderly patients with dementia-related psychosis and suicidal thoughts and behaviors in children, adolescents, and young adults. The drug is available as an oral solution and has various dosing recommendations for different conditions and patient populations. Special population considerations include use during pregnancy, nursing mothers, pediatric use, and geriatric use.
Increased mortality in elderly patients with dementia-related psychosis and suicidal thoughts and behaviors in children, adolescents, and young adults
Dose adjustments may be necessary for patients with hepatic or renal impairment, or those taking concomitant medications that affect CYP2D6 or CYP3A4
10-15 mg/day
2 mg/day, titrated to 10 mg/day
15 mg/day
2 mg/day, titrated to 10 mg/day
Not recommended
2 mg/day, titrated to 5-10 mg/day
Not recommended
2 mg/day, titrated to 5-10 mg/day
ARIPIPRAZOLE ORALLY DISINTEGRATING
ScieGen Pharmaceuticals Inc
ARIPIPRAZOLE
Proficient Rx LP
ARIPIPRAZOLE LAUROXIL
Alkermes, Inc.
QUETIAPINE EXTENDED-RELEASE
Amneal Pharmaceuticals LLC
RISPERIDONE
REMEDYREPACK INC.